[1]
Malataras, P. and Pallikarakis, N. 2018. Spin-off use of adverse events data: why and how. The case of FDA’s MAUDE. Global Clinical Engineering Journal. 1, 1 (Oct. 2018), 9-23. DOI:https://doi.org/10.31354/globalce.v1i1.32.